tiprankstipranks
Advertisement
Advertisement

Why Novartis Stock Is Slipping After Huge Bond Deal

Why Novartis Stock Is Slipping After Huge Bond Deal

Novartis ( (NVS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.

Claim 30% Off TipRanks

Novartis shares came under pressure as investors reacted cautiously to the company’s latest funding move, worried about the impact of higher debt on future returns and risk. Some see the large deal as a sign that management is preparing for uncertain markets, which can unsettle shorter-term holders.

The company disclosed an $11 billion U.S. dollar bond sale by Novartis Capital, fully guaranteed by the parent, with floating and fixed notes maturing between 2029 and 2056 to strengthen long-term funding and flexibility. Despite the mixed sentiment, several analysts are edging their price targets higher, signaling confidence in Novartis’s longer-term strategy.

More about Novartis

YTD Price Performance: 14.52%

Average Trading Volume: 2,276,711

Technical Sentiment Signal: Buy

Current Market Cap: $295.1B

For further insights into NVS stock on TipRanks’ Stock Analysis page.

See more of today’s top stock gainers and losers.

Disclaimer & DisclosureReport an Issue

1